Hostname: page-component-78c5997874-4rdpn Total loading time: 0 Render date: 2024-11-14T17:24:32.196Z Has data issue: false hasContentIssue false
  • English
  • Français

Mitochondrial myopathies and anaesthesia

Published online by Cambridge University Press:  23 December 2004

E. A. Shipton  and
D. O. Prosser
E. A. Shipton
Affiliation:
University of Otago, Christchurch School of Medicine and Health Sciences, Department of Anaesthesia, Christchurch, New Zealand
D. O. Prosser
Affiliation:
University of Otago, Christchurch School of Medicine and Health Sciences, Department of Anaesthesia, Christchurch, New Zealand
Get access

Abstract

Summary

The mitochondrial myopathies consist of a heterogeneous group of disorders caused by structural and functional abnormalities in mitochondria leading to involvement of the nervous system and muscles as well as other organ systems. The peculiar genetic characteristics of mitochondrial DNA impart distinctive properties to these disorders. The pathophysiology is presented. The methods employed in making the correct diagnosis, the preoperative patient assessment and correction of metabolic dysfunctions and anaesthetic techniques used, are highlighted. The conditions are briefly reviewed and suggestions are made for the safe anaesthetic management of affected patients.

Keywords

ANAESTHESIA, general, regionalMITOCHONDRIAL MYOPATHIES, MELAS syndrome, Kearns-Sayre syndrome, MERRF syndrome, Leigh disease
Type
Review
Information
European Journal of Anaesthesiology , Volume 21 , Issue 3 , March 2004 , pp. 173 - 178
Copyright
2004 European Society of Anaesthesiology

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Morgan P, Hoppel CL, Sedensky MM. Mitochondrial defects and anesthetic sensitivity. Anesthesiology 2002; 96: 1268–1270.Google Scholar
Plasterer TN, Smith TF, Mohr SC. Survey of human mitochondrial diseases using new genomic/proteomic tools. Gene Biol 2001; 2: 1–16.Google Scholar
Solano A, Playan A, Loez-Perez MJ, Montoya J. Genetic diseases of the mitochondrial DNA in humans. Salud Publica Mexico 2001; 43: 151–161.Google Scholar
Rosaeg OP, Morrison S, MacLeod JP. Anaesthetic management of labour and delivery in the parturient with mitochondrial myopathy. Can J Anaesth 1996; 43: 403–407.Google Scholar
Mehndiratta MM, Agarwal P, Tatke M, Krishnamurthy M. Neurological mitochondrial cytopathies. Neurol India 2002; 50: 162–167.Google Scholar
Wisely NA, Cook PR. General anaesthesia in a man with mitochondrial myopathy undergoing eye surgery. Eur J Anaesthesiol 2001; 18: 333–335.Google Scholar
Hsiao PN, Cheng TJ, Tseng HC, Chuang YH, Kao PF, Tsai SK. Spinal anesthesia in MELAS syndrome: a case with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes. Acta Anaesthesiol Sin 2000; 38: 107–110.Google Scholar
Wredenberg A, Wibom R, Wilhelmsson H, et al. Increased mitochondrial mass in mitochondrial myopathy mice. Proc Natl Acad Sci USA 2002; 99: 15066–15071.Google Scholar
Schapira AH. Mitochondrial disorders. Biochem Biophys Acta 1999; 1410: 99–102.Google Scholar
Wallace JJ, Perndt H, Skinner M. Anaesthesia and mitochondrial disease. Paediatr Anaesth 1998; 8: 249–254.Google Scholar
Ciccotelli KK, Prak EL, Muravchick S. An adult with inherited mitochondrial encephalopathy: report of a case. Anesthesiology 1997; 87: 1240–1242.Google Scholar
Cheam EWS, Critchley LAH. Anesthesia for a child with complex I respiratory chain enzyme deficiency. J Clin Anesth 1998; 10: 524–527.Google Scholar
Dalta V, Jain P, Mehndirrata MM, et al. Myoclonic epilepsy with red ragged fibres. Indian Pediatr 1999; 36: 817–819.Google Scholar
Nouette-Gaulain K, Forestier F, Malgat M, Marthan R, Mazat JP, Sztark F. Effects of bupivacaine on mitochondrial energy metabolism in heart of rats following exposure to chronic hypoxia. Anesthesiology 2002; 97: 1507–1511.Google Scholar
Farag E, Argalious M, Narouze S, DeBoer G, Tome J. The anesthetic management of ventricular septal defect (VSD) repair in a child with mitochondrial cytopathy. Can J Anaesth 2002; 49: 958–962.Google Scholar
Thompson VA, Wahr JA. Anesthetic considerations in patients presenting with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) syndrome. Anesth Analg 1997; 85: 1404–1406.Google Scholar
Sharma AD, Erb E, Schulman SR, Sreeram G, Slaughter TF. Anaesthetic considerations for a child with combined Prader–Willi syndrome and mitochondrial myopathy. Paediatr Anaesth 2001; 11: 488–490.Google Scholar
Taivassalo T, Abbott A, Wyrick P, Haller RG. Venous oxygen levels during aerobic forearm exercise: and index of impaired oxidative metabolism in mitochondrial myopathy. Ann Neurol 2002; 51: 38–44.Google Scholar
Ohtani Y, Miike T, Ishitsu T, et al. A case of malignant hyperthermia with mitochondrial dysfunction. Brain Dev 1985; 7: 249.Google Scholar
Steensberg A, Vissing J, Pedersen BK. Lack of IL-6 production during exercise in patients with mitochondrial myopathy. Eur J Appl Physiol 2001; 84: 155–157.Google Scholar
Vladutiu GD, Bennett MJ, Smail D, Wong LJ, Taggart RT, Lindsley HB. A variable myopathy associated with heterozygosity for the R503C mutation in the carnitine palmitoyltransferase II gene. Mol Genet Metab 2000; 70: 134–141.Google Scholar